Exagen Inc Share Price

NASDAQ: XGN

Small Cap

$9.45

+0.34

(+3.73%)

Live

as on September 17, 2025 at 11:37 pm IST

$₹

Exagen Inc Stock Performance

as on September 17, 2025 at 11:37 pm IST

Day's Low
Day's High
$9.02
Day's Price Range
$9.35
$9.45
4.55%
Downside
-1.06%
Upside
52 Week's Low
52 Week's High
$2.38
52-Week Price Range
$10.34
$9.45
74.81%
Downside
9.42%
Upside

Exagen Inc share price movements today

Previous Close: $9.11
Open: $9.09
Volume: 97.5K
Day's Low - High: $9.02 - $9.35
52 Week Low - High: $2.38 - $10.34

Exagen Inc Historical Returns

1 Month Return: -4 %
3 Month Return: + 17.85 %
1 Year Return: + 228.88 %
3 Year Return: + 92.6 %
5 Year Return: -30.35 %

Exagen Inc Stock Fundamentals & Key Indicators

Check Exagen Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$200.5M

EPS (TTM)

-0.6975

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3

Industry PE ratio

-3.9281873111782475

P/B Ratio

PEG Ratio

EBITDA

-12.3M

Revenue (TTM)

58.9M

Profit Margin

-28.85%

Return On Equity TTM

4389100.00%

Exagen Inc Stock Valuation

Track how Exagen Inc P/E has moved over time to understand its valuation trends.

Exagen Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (-3.93x)

September 17, 2025

Today (-3.00x)

September 17, 2025

Highest (-0.96x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -3.00x

Exagen Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Exagen Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Exagen Inc	BUY	$200.5M	-30.35%	-3	-28.85%
Idexx Laboratories, Inc.	BUY	$51.7B	82.28%	53.76	24.41%
Agilent Technologies Inc.	BUY	$36.1B	27.7%	29.72	17.97%
Iqvia Holdings Inc.	BUY	$31.8B	16.39%	27.07	7.88%
Thermo Fisher Scientific, Inc.	BUY	$181.5B	11.04%	27.77	15.24%

See all

Stock Returns calculator for Exagen Inc Stock including INR - Dollar returns

The Exagen Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Exagen Inc investment value today

Current value as on today

₹3,45,754

Returns

₹2,45,754

(+245.75%)

Returns from Exagen Inc Stock

₹2,41,155 (+241.16%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Exagen Inc Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Exagen Inc. Average target price of $11.71

Exagen Inc Share Price Target

Get share price movements and forecasts by analysts on Exagen Inc.

What analysts predicted

19.3%UPSIDE

Target Price

$11.71

Current Price

$9.45

Analyzed by

10 Analysts

Target

$11.71

Exagen Inc target price $11.71, a slight upside of 19.3% compared to current price of $9.45. According to 10 analysts rating.

Exagen Inc Stock's Interest Amongst Investors

Search interest for Exagen Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:-67% versus previous 30 day period

Exagen Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	11	14	13	13	14	15	12	13	15	17
Gross Profit	5	8	7	8	8	9	6	8	9	10
Operating Income	-7	-4	-5	-5	-3	-2	-4	-3	-3	-2
EBITDA	-6	-3	-4	-4	-2	-1	-4	-2	-2	-2
Interest Expense	0	0	0	0	0	0	0	0	0	1
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-5	-5	-5	-3	-2	-5	-3	-3	-4
Income Tax Expense	0	0	0	0	0	-	-	0	-3	0
Net Income	-7	-5	-5	-5	-3	-2	-5	-3	-3	-4
Net Profit Margin	-68.46%	-35.46%	-40.36%	-40.49%	-23.31%	-19.69%	-40.20%	-27.54%	-24.21%	-25.81%

Exagen Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2014	Dec 2015	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	11	17	26	32	40	41	48	45	52	55
Gross Profit	4	8	12	17	21	25	27	21	29	33
Operating Income	-11	-10	-7	-4	-9	-15	-24	-40	-22	-13
EBITDA	-11	-13	-22	-4	-7	-13	-23	-43	-19	-11
Interest Expense	2	4	2	2	3	2	2	2	2	2
Depreciation	-	-	0	0	0	0	0	1	2	1
Income Before Tax	-14	-18	-26	-7	-12	-16	-26	-47	-23	-15
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-14	-19	-25	-8	-12	-16	-26	-47	-23	-15
Net Profit Margin	-128.45%	-106.89%	-95.61%	-24.70%	-29.81%	-39.75%	-55.59%	-104.00%	-45.08%	-27.17%

Exagen Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-5	-5	-5	-3	-2	-5	-3	-3	-4
Operating Cash Flow	-10	-2	8	-9	-2	-2	0	-10	-2
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	-10	0	0	0	0	0	0	0	21
Change in Cash	-20	-3	8	-9	-2	-2	0	-10	18

Exagen Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2015	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-19	-25	-8	-12	-16	-26	-47	-23	-15
Operating Cash Flow	-11	-10	-9	-9	-14	-20	-32	-14	-13
Investing Cash Flow	0	0	0	0	0	-2	-4	0	0
Financing Cash Flow	10	19	11	68	0	64	0	-10	0
Change in Cash	-2	7	1	58	-14	41	-36	-25	-14

Global Institutional Holdings in Exagen Inc

Funds	Holdings
RTW INVESTMENTS, LLC	6.87%
The Toronto-Dominion Bank	4.05%
Silvercrest Asset Management Group LLC	2.42%
Vanguard Group Inc	2.23%
Morgan Stanley - Brokerage Accounts	2.21%

See all

Insights on Exagen Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, XGN has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 12.50M → 17.20M (in $), with an average increase of 10.1% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, XGN has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Price Dip
In the last 7 days, XGN stock has moved down by -5.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -3.75M → -4.43M (in $), with an average decrease of 18.3% per quarter

About Exagen Inc

exagen diagnostics, inc. is a patient focused, discovery driven, clia-certified, cap-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of rheumatology and autoimmune diseases. committed to personalized medicine, our avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management. for more information on our company, please visit www.exagen.com. for more information on avise testing services, please visit www.avisetest.com.

Organisation	Exagen Inc
Headquarters	1261 Liberty Way, Vista, CA, United States, 92081
Industry	Health Services
CEO	Mr. John Aballi
E-voting on shares	Click here to vote

Key Management of Exagen Inc

Name	Title
Mr. Jeffrey G. Black	CFO & Corporate Secretary
Dr. Michael Mahler	Chief Scientific Officer
Mr. Ryan Douglas	Investors Relations Officer
Dr. Michael I. Nerenberg M.D.	Chief Medical Officer
Dr. Tina S. Nova Ph.D.	Executive Chairman of the Board of Directors
Mr. John Aballi	CEO, President & Director

FAQs

What is Exagen Inc share price today?

Exagen Inc share price today is $9.45 as on September 17, 2025 at 11:37 pm IST. Exagen Inc share today touched a day high of $9.35 and a low of $9.02.

What is the 52 week high and 52 week low for Exagen Inc share?

Exagen Inc share touched a 52 week high of $10.34 on August 22, 2025 and a 52 week low of $2.38 on November 6, 2024. Exagen Inc stock price today i.e. September 17, 2025 at 11:37 pm IST is trending at $9.45,which is 8.61% down from its 52 week high and 297.06% up from its 52 week low.

What is Exagen Inc's market capitalisation today?

Exagen Inc market capitalisation is $0.00T as on September 17, 2025 at 11:37 pm IST.

How to invest in Exagen Inc Stock (XGN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Exagen Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Exagen Inc Shares that will get you 0.1587 shares as per Exagen Inc share price of $9.45 per share as on September 17, 2025 at 11:37 pm IST.

What is the minimum amount required to buy Exagen Inc Stock (XGN) from India?

Indian investors can start investing in Exagen Inc (XGN) shares with as little as ₹87.816 or $1 (as of September 17, 2025 at 11:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Exagen Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 11:38 pm IST). Based on Exagen Inc share’s latest price of $9.45 as on September 17, 2025 at 11:37 pm IST, you will get 1.0582 shares of Exagen Inc. Learn more about fractional shares .

What are the returns that Exagen Inc has given to Indian investors in the last 5 years?

Exagen Inc stock has given -30.35% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?